EZH2 and neoplasm: Epigenetic regulators such as EZH2 are also upregulated in UM, suppressing tumor-suppressor genes and inhibiting T-cell infiltration—a phenomenon recently identified as potentially targetable by specific therapies (Li et al., 2025).